Behavioral and cardiovascular effects of intravenous methylphenidate in normal subjects and cocaine abusers

European Addiction Research

Volumn 3, Issue 1, 1997, Pages 49-54

  Wanga, Gene Jack ^a,b   Volkow, Nora D ^a,b   Hitzemann, Robert J ^b,c   Wonga, Christopher ^a   Angrist, Burton ^d   Burrd, Gail ^c   Pascani, Kathy ^c   Pappas, Naomi ^a   Lu, Angela ^a   Cooper, Thomas ^d   Lieberman, Jeffrey A ^e  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Behavior; Cardiovascular effect; Cocaine; Methylphenidate

Indexed keywords

COCAINE; METHYLPHENIDATE; PSYCHOSTIMULANT AGENT;

ADULT; ARTICLE; BEHAVIOR; BLOOD PRESSURE; CARDIOVASCULAR EFFECT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIBIDO; MALE; PRIORITY JOURNAL; PULSE RATE; RESTLESSNESS; SELF CONTROL;

EID: 12644252014     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000259147     Document Type: Article

References (25)

1. Kaufmann MW, Casscm NH, Murray GB, Jenike M: Use of psychostimulants in medically ill patients with neurological disease and major depression. Can J Psychiatry 1984;29:46-49.
2. Pollack MH, Brotman AW, Rosenbaum JF: Cocaine abuse and treatment. Compr Psychiatry' 1989:30:31-44.
3. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ: Cocaine receptors on dopamine transporters arc related to self-administration of cocaine. Science 1987;237:1219-1223.
4. Wilson MC, Hitomi M, Schuster CR: Psychomotor self administration as a function of dosage per injection in the rhesus monkey. Psychopharmacology 1971:22:271-281.
5. Johanson CE, Shuster CR: A choice procedure for drug reinforcers: cocaine and methylpheni-datc in the rhesus monkey. J Pharmacol Exper Ther 1975;193:676-688.
6. Bergman J, Madras B, Johnson SE, Spealman RD: Effects of cocaine and related drugs in nonhuman primates. III. Self administration by squirrel monkeys. J Pharmacol Exp Ther 1989;251:150-155.
7. Parran TV, Jasinski DR: Intravenous methyl-phenidatc abuse. Arch Intern Med 1991:151: 781-783.
8. Hoffman BB, Lefkowitz RJ: Catecholamines and sympathomimetic drugs; in Gilman AG. Rail TW. Nies AS. Taylor P (cds): Goodman and Gilman’s The pharmacological basis of therapeutics. New York, Pergamon, 1990, vol 10, pp 187-220.
9. Wargin W, Kilts PC, Gualtieri CT, Ellinton K, Mueller RA, KraemerG, Breese GR: Pharmacokinetics of mcthylphenidate in man. rat and monkey. J Pharmacol Exp Ther 1983:226:382-386.
10. Javaid J, Fischman MW, Schuster CR. Davis JM: Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 1978:201:227-228.
11. Jcffcoat AR, Perez Reyes M, Hill JM, Sadler BM, Cook CE: Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting) or smoking. Drug Metab Dispos Biol FateChem 1989:17:153-159.
12. Chait LD: Reinforcing and subjective effects of mcthylphenidate in humans. Behav Pharmacol 1994:4:281-288.
13. Bell RD, Alexander GM, Schwartzman RJ: Methylphenidate decreases local glucose metabolism in the motor cortex. Pharmacol Bio-chem Behav 1983;18:1-5.
14. Porrino LJ, Lucignani G: Different patterns of local brain energy metabolism associated with high and low dose of methylphenidate. Relevance to its actions in hyperactive children. Biol Psychol 1987;22:126-138.
15. London ED, Wilkerson G, Goldberg SR, Ris-ner ME: Effects of /-cocaine on local cerebral glucose utilization in the rat. Ncurosci Lett 1986:68:73-78.
16. Porrino LJ, Domer FR, Crane AM, Sokoloff L: Selective alterations in cerebral metabolism within the mesocorticolimbic dopaminergic system produced by acute cocaine administration in rats. Neuropsychopharmacology 1988; 1:109-118.
17. Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schyler DJ, MacGregor RR, Hitzemann R, Logan J, Bcndriem B, Gatlcy, SJ, Christman D: Mapping cocaine binding sits in human and baboon brain in vivo. Synapse 1989:4:371-377.
18. Foltin RW, Fischman M: Smoked and intravenous cocaine in humans: Acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 1991:257:247-261.
19. Joyce PR, Nicholls MG, Donald RA: Methylphenidate increases heart rate, blood pressure and plasma epinephrine in normal subjects. Life Sei 1984:34:1707-1711.
20. Lucas PB, Gardner DL, Wolkowitz OM, Tucker EE. Cowdry RW: Methylphcnidate-induccd cardiac arrhythmias (letter). N Engl J Med 1986:315:1485.
21. Volkow ND, Fowler JS, Wolf AP, Schlyer D, Shiue C-Y, Dewey SL, Alpert R, Logan J, Christman D, Bcndriem B. Hitzemann R, Hcnn F: Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990;147:719-724.
22. Volkow ND, Fowler JS, Wang G-J, Hitzemann R, Logan J, Schlyer D, Dewey S, Wolf AP: Dopaminergic disregulation of frontal metabolism may contribute to cocaine addiction. Synapse 1993:14:169-177.
23. Gawin FH, Riordan C, Kleber H: Methylphe-nidaie treatment of cocaine abusers without attention deficit disorders: Negative report. Am J Drug Alcol Abuse 1985;11:193-197.
24. Gawin FH, Ellinwood EH Jr: Consequences and correlates of cocaine abuse: Clinical phenomenology; in Volkow ND. Swann AC (eds): Cocaine in the brain. Rutgers. New Brunswick, 1991, vol 8. pp 155-178.
25. Dews PB, Wenger GR: Rate-dependency of the behavioral effects of amphetamine. Adv Behav Pharmacol 1977;1:167-227.